Vertiv Holdings shares dropped after its fourth-quarter earnings beat expectations but its guidance underwhelmed the market.

It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain.

CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy ...

Gilead Sciences (GILD) could open near nine-year highs after beating fourth-quarter earnings and revenue estimates ...

The company’s subscription-based software is being rapidly adopted by customers, and AI opportunities are proving to be ...

Dominion Energy raised its five-year capital expenditure plan on Wednesday as the utility firm sought to cash in on the ...

The company reported $261 million in revenue and adjusted earnings of $0.09 per share, slightly above analysts' consensus ...

Stock futures slip as traders await CPI data, Fed policy updates, and key earnings. Will inflation cool, or will Powell’s ...

The company reported revenue of $219 million and earnings of $0.26 per share, surpassing the consensus estimates of $181 ...

Over the last few years, this under-the-radar technology business has quietly become one of the largest companies in the FTSE ...

Lyft shares tumbled close to 14% in premarket trading on Wednesday after the company issued weaker-than-expected guidance for ...

DALLAS, Feb. 12, 2025 (GLOBE NEWSWIRE) -- P10, Inc. (NYSE: PX) (the "Company”), a leading private markets solutions provider, ...